» Articles » PMID: 9590488

A Step in the Right Direction: Assessing Exercise Tolerance in Cystic Fibrosis

Overview
Date 1998 May 20
PMID 9590488
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Exercise tolerance may be reduced in patients with cystic fibrosis, but it is not always possible to predict this from standard lung function measurements. Formal exercise testing may, therefore, be necessary, and the test should be simple and readily available. We have developed a "3-minute step test" and compared it with the standard 6-minute walking test. Subjects stepped up and down a 15-cm-high single step at a rate of 30 steps per minute for 3 minutes. The effect of the step test on spirometry was tested first in 31 children with CF (mean age, 12.0 years), who had a mean (range) baseline forced expired volume in 1 second (FEV1) of 64% (18-94%) of predicted values. The step test was then compared with the standard 6-minute walk in a further 54 patients with cystic fibrosis (mean age, 12.5 years), with mean (range) baseline FEV1 of 61% (14-103%) of predicted values. Outcome measures were minimum arterial oxygen saturation (SaO2), maximum pulse rate, and the modified Borg dyspnea score. Post-step test spirometry showed mean (95% CI) changes of -1.1% (-6.0 + 3.9%) for forced vital capacity, of -1.6% (-4.2 + 1.1%) for FEV1, and +0.25% (-2.8 + 3.3%) for peak expiratory flow, although 5/31 children showed >15% drop in one or more parameters. The step and walk tests both produced significant changes (P < 0.0001) in all outcomes, with a mean (range) minimum SaO2 of 92% (75-98%) versus 92% (75-97%), a maximum pulse rate of 145 b.p.m. (116-189) versus 132 (100-161), and a Borg score of 2.5 (0-9) versus 1.0 (0-5), respectively. Comparison of the two tests showed that the step test increased breathlessness (mean change Borg score, 2.3 vs. 0.8; P < 0.0001) and pulse rate (mean change, 38% vs. 24%, P < 0.0001) significantly more than the walk, whereas the decrease in SaO2 was similar (mean change, -2.9% vs. -2.6%; P = 0.12). Some patients with a significant drop in SaO2 (>4%) would not have the decrease predicted from their baseline lung function. Reproducibility for the two tests was similar. The step test is quick, simple and portable, and is not dependent on patient motivation. Although the step test is more tiring, its effect on SaO2 is similar to the 6-minute walking test. It is a safe test that may prove to be a valuable measure of exercise tolerance in children with pulmonary disease, although longitudinal studies are now needed.

Citing Articles

Clinimetric properties of field exercise tests in cystic fibrosis: a systematic review.

Corda J, Holland A, Tannenbaum E, Cox N Eur Respir Rev. 2024; 33(174).

PMID: 39694588 PMC: 11653197. DOI: 10.1183/16000617.0142-2024.


VO2MAX, 6-minute walk, and muscle strength each correlate with frailty in US veterans.

Seldeen K, Rahman A, Redae Y, Satchidanand N, Mador M, Ma C Front Physiol. 2024; 15:1393221.

PMID: 39345785 PMC: 11427282. DOI: 10.3389/fphys.2024.1393221.


Randomized crossover trial of a demand oxygen delivery system in nocturnal hypoxemia.

Yatani A, Nagano T, Murakami S, Otoshi T, Hazama D, Katsurada N Sci Rep. 2024; 14(1):20505.

PMID: 39227657 PMC: 11372129. DOI: 10.1038/s41598-024-71320-7.


Feasibility of performing the 3-minute step test with remote supervision in children and adolescents with cystic fibrosis: A comparative study.

Vendrusculo F, da Costa G, Bagatini M, Lemes B, Faria C, de Oliveira L Pediatr Investig. 2024; 8(2):83-90.

PMID: 38910852 PMC: 11193376. DOI: 10.1002/ped4.12436.


Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review.

Palmer T, Obst S, Aitken C, Walsh J, Sabapathy S, Adams L Eur Respir Rev. 2023; 32(169).

PMID: 37558262 PMC: 10410401. DOI: 10.1183/16000617.0016-2023.